ArticleEuropean heart journal. Cardiovascular pharmacotherapy2026

SGLT2 inhibitors are associated with improved long-term survival in Takotsubo syndrome: insights from large-scale real-world data.

Elias Rawish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.